1. Yost ML. Critical limb ischemia by Rutherford Category: prevalence and markets in patients and limbs. Beaufort (SC); THE SAGE GROUP; 2017.
  2. Hirsch AT, et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary. Circulation. 2006;113:e463-e654.
  3. Allie DE, Hebert CJ, Ingraldi A, Patlola RR, Walker CM. 24-Carat Gold, 14-Carat Gold, or Platinum Standards in the Treatment of Critical Limb Ischemia: Bypass Surgery or Endovascular Intervention? J Endovsc Ther. 2009;16(Suppl I):I134–I146.
  4. Davies MG. Critical Limb Ischemia: Epidemiology. Methodist Debakey Cardiovasc J. 2012, VIII (4):10-14.
  5. Henry AJ, et al. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. J Vasc Surg. 2011;53-330-e1.
  6. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics — 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-e171.
  7. Hirsch AT, Murphy TP, Lovell MB, et al. Gaps in Public Knowledge of PAD: the First National PAD Public Awareness Survey. Circulation. 2007; 116:2086-2094.
  8. U.S. Department of Health & Human Services; National Institute of Health; National Heart, Lung, and Blood Institute, August 2006 2011.
  9. Guzman RJ, et al. Tibial artery calcification as a marker of amputation risk in patients with PAD. J Am Coll Cardiol. 2008 May 20; 51(20): 1967–1974.
  10. Moyer-Harris A. The Underestimation of PAD & Its Impact On Wound Care. Today’s Wound Clinic. 2015: June/July 10-13.
  11. Allison MA, Criqui MH, Wright M. Patterns and Risk Factors for Systemic Calcified Atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:331-336.
  12. Graziani L, Piaggesi A. Indications and Clinical Outcomes for Below Knee Endovascular Therapy: Review Article. Catheterization and Cardiovascular Interventions. 2010; 75:433–443.
  13. Olin JW, et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease. J Am Coll Cardiol. 2010:2147–81.
  14. Rhim B, Harkless L. Prevention: Can We Stop Problems Before They Arise? Semin Vasc Surg. 2012, 25:122-128.
  15. Ephraim PL, et al. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil. 2005; 86:1910-19.
  16. Allie DE, et al. Critical limb ischemia: a global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention. 2005, 1 (1):75-84.
  17. Choksi N. Endovascular Treatments for Critical Limb Ischemia. Medicine Update. 2010, Vol. 10:386-390.
  18. Weinstock B, Dattilo R, Diage T. Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions. Clinicoecon Outcomes Res. 2014:6 133–139.
  19. Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes—a review. Diabet Med. 2010, 27, 4–14.
  20. Lumsden AB, Davies MG, Peden EK. Medical and Endovascular Management of Critical Limb Ischemia. J Endovasc Ther. 2009;16(Suppl II):II31–II62.
  21. Miller S. Arterial disease: Lower extremity implications. Lower Extremity Review. 2010; 2(9): 55-61.
  22. Alvarsson A, Sandgren B, Wendel C, Alvarsson M, Brismar K. A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented? Cardiovas Diabetol. 2012, 11:18.
  23. White C, Gray W. Endovascular Therapies for Peripheral Arterial Disease: An Evidence-Based Review. Circulation. 2007;116:2203-2215.
  24. Knepper JP, Henke PK. Diagnosis, Prevention, and Treatment of Claudication. Surg Clin North Am. 93 (2013) 779–788.
  25. Jones WS, et al. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J. 2013;165:809-815.e1
  26. Makam P. Use of Orbital Atherectomy Treatment in a High-Volume Clinical Practice Modifies Non-Compliant Plaque to Deliver Durable Long-Term Results. J Invasive Cardiol. 2013;25(2):85-88.
  27. Mohler ER. Peripheral Arterial Disease: Identification and Implications. Arch Intern Med. 2003;163:2306-2314.
  28. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.
  29. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group. Intersociety consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007 Jan;45(1 Suppl):S5-S67.
  30. Mayeda G, et al. Procedural Outcomes of Orbital Atherectomy Treatment of Peripheral Arterial Disease in an Outpatient Office-Based vs Hospital Setting. Vascular Disease Management. 2014;11(2):E37-E43.
  31. Rundback JH, Herman KC. Techniques in VIR: Optimal use of Atherectomy in CLI. Tech Vasc Interv Rad. 2014; Sep;17(3):211-8.
  32. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54-60.
  33. Saab F et al. The Nuts and Bolts of Building a Critical Limb Ischemia Program. Accessed Sep 15, 2015.
  34. Olin JW, Sealove BA. Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management. Mayo Clin Proc. 2010 Jul; 85(7): 678-692.
  35. Mayo Clinic Website
  36. Mayo Clinic Website
  37. Aboyans V, et al. Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels. Circulation. 2006;113:2623-2629.
  38. Goodney PP, et al. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013;57:1471-80.
  39. Adams GL, Khanna PK, Staniloae CS, Abraham JP, Sparrow EM. Optimal Techniques with the Diamondback 360° System Achieve Effective Results for the Treatment of Peripheral Arterial Disease. J Cardiovasc Transl Res. 02/2011; 4(2):220-9.
  40. American Diabetes Association. (2003). Peripheral arterial disease in people with diabetes. Diabetes care, 26(12), 3333-3341.
  41. Howlader N, et al. SEER Cancer Statistics Review, 1975-2010. Accessed April 17, 2014.
  42. Go AS, et al. Heart Disease and Stroke Statistics – 2014 Update: A report from the American Heart Association. Circulation. 2014;129:e28 292.
  43. Dolor RJ, et al. Treatment Strategies for Women With Coronary Artery Disease. Comparative Effectiveness Reviews. No. 66. 2012 Aug.
  44. LaMendola B, Altrichter J, Cutillo A, et al. Peripheral Arterial Disease and the CKD Patient: The Case for Early Screening, Diagnosis, and Minimally Invasive Revascularization. Dialysis & Transplantation. 2010; DOI: 10.1002/dat.20498.
  45. Humphries, MD, Brunson, A, Hedayati, N, Romano, P & Melnkow, J. Amputation risk in patients with diabetes mellitus and peripheral artery disease using statewide data. Annals of Vasculary Surgery, 2016. 30, 123-131.
  46. Liew, YP. Bartholomew JR, Demirijian S, et al. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. CJASN, 2008. 3(4), 1084-1089.
  47. Mustapha, JA, Fisher, BT, Rizzo, JA, Chen, J, Martinsen, BJ, Kotlarz, H, and Gunnarsson, C. Explaining Racial Disparities in Amputation Rates for the Treatment of Peripheral Artery Disease (PAD) Using Decomposition Methods. Journal of Racial and Ethnic Health Disparities, 2017;1-12.
  48. Rizzo, JA, Chen, J, Kotlarz, H, Ryan, MP, & Gunnarsson, C. Racial Disparities in Amputation Rates for the Treatment of Peripheral Artery Disease Using the Health Care Cost and Utilization Project Database. Value in Health, 2016;19(3), A55-A56.
  49. Criqui, M. & Aboyans, V; Circ Res. 2015;116:1509-152.
  50. U.S. Department of Health & Human Services; National Institute of Health; National Heart, Lung, and Blood Institute Accessed April 16, 2018.
  51. Olin, JW, White, CJ, Armstrong, EJ, Kadian-Dodov, D and Hiatt, WR. Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options. Journal of the American College of Cardiology, 2016;67(11), 1338-1357.
  52. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10. 2012 Jan;(252):1-207.
  53. Noone AM, et al. (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD,, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
  54. Benjamin EJ, et al. Circulation. 2017;135:e146-e603.
  56. Barnett, ML, Ray, KN, Souza, J, Mehrotra, A. Trends in telemedicine use in a large commercially insured population, 2005-2017. JAMA, 2018:320(20), 2147-2149.
  57. “”> August 14, 2020.
  58. Coombs, B. Telehealth visits are booming as doctors and patients embrace distancing amid the coronavirus crisis. CNBC. Apr 4, 2020. Accessed May 29, 2020.
  59. Schiavetta A, et al. A Phase II Trial of Autologous Transplantation of Bone Marrow Stem Cells for Critical Limb Ischemia: Results of the Naples and Pietra Ligure Evaluation of Stem Cells Study. Stem Cells Transl Med. 2012; 1:572-578.
  60. Uccioli, L, Meloni, M, Izzo, V, Giurato, L, Merolla, S, & Gandini, R. Critical limb ischemia: current challenges and future prospects. Vascular health and risk management,2018;14, 63.
  61. Fisher ES, Goodman DC, Chandra A. Disparities in Health and Health Care among Medicare Beneficiaries: A Brief Report of the Dartmouth Atlas Project. Robert Wood Johnson Foundation 2008.
  62. Rizzo JA, Chen J, Laurich C, Santos A, Martinsen BJ, Ryan MP, Kotlarz H, Gunnarsson C. Racial Disparities in PAD-Related Amputation Rates among Native Americans and non-Hispanic Whites: An HCUP Analysis. J Health Care Poor Underserved. 2018;29(2):782-800. doi:10.1353/hpu.2018.0058
  63. Matsushita, K, Sang, Y, Ning, H, Ballew, SH, Chow, EK, Grams, ME & Wilkins, JT. Lifetime Risk of Lower‐Extremity Peripheral Artery Disease Defined by Ankle‐Brachial Index in the United States. Journal of the American Heart Association, 2019;8(18), e012177.
  64. Fu X, Zhang Z, Liang K, et al. Angioplasty versus bypass surgery in patients with critical limb ischemia-a meta-analysis. Int J Clin Exp Med. 2015;8(7):10595-10602.
  65. Meltzer AJ, Sedrakyan A, Isaacs A, Connolly PH, Schneider DB; Vascular Study Group of Greater New York. Comparative effectiveness of peripheral vascular intervention versus surgical bypass for critical limb ischemia in the Vascular Study Group of Greater New York. J Vasc Surg. 2016;64(5):1320-1326.e2. doi:10.1016/j.jvs.2016.02.06
  66. Tsai TT, Rehring TF, Rogers RK, et al. The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease. Circulation. 2015;132(21):1999-2011. doi:10.1161/CIRCULATIONAHA.114.013440

Site sponsored by Cardiovascular Systems, Inc.®
CSI®, Take A Stand Against Amputation®, the Take A Stand “Badge” and Stylized “A” are trademarks of Cardiovascular Systems, Inc.

CSI is now Abbott. Learn more.

Learn More About PAD

"*" indicates required fields


This site is not intended as a substitute for professional medical care.

Only a health care professional can diagnose and appropriately treat your symptoms.

Copyright ©2018-present Cardiovascular Systems, Inc. All rights reserved.
Site Created by The Deciding Factor Inc.

References  |  Terms of UseSitemap

We take privacy seriously. We will not share your personal information to third parties, except as described in our privacy statement.